RWM
PFE icon

Revisor Wealth Management’s Pfizer PFE Stock Holding History

Revisor Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Sell
30,193
-836
-3% -$21.9K 0.17% 144
2026
Q1 		$871K Buy
31,029
+415
+1% +$11K 0.24% 110
2025
Q4 		$783K Buy
30,614
+12,830
+72% +$324K 0.21% 115
2025
Q3 		$449K Buy
17,784
+751
+4% +$18.5K 0.15% 143
2025
Q2 		$439K Buy
+17,033
New +$397K 0.16% 152

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Revisor Wealth Management's PFE Position: Q2 2026 in Review

Revisor Wealth Management reduced its Pfizer (PFE) stake by 2.7% in Q2 2026, selling an estimated $21.9K and leaving 30,193 shares worth $727K. The position accounts for 0.17% of the portfolio, ranked #144.

Revisor Wealth Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $871K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Revisor Wealth Management held 30,193 shares of Pfizer worth $727K as of Q2 2026.
  • Revisor Wealth Management sold 836 Pfizer shares in Q2 2026, an estimated $21.9K.
  • Pfizer made up 0.17% of Revisor Wealth Management's portfolio in Q2 2026, its #144 holding.
  • Revisor Wealth Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Revisor Wealth Management's Pfizer position peaked at $871K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.